Direct Access Testing in the Philippines: A Critical Commentary on Policy–Practice Gaps and Regulatory Directions

Abstract Direct Access Testing (DAT) has gained increasing global attention as healthcare systems place greater emphasis on patient autonomy, preventive and improved access to health information. This model is an innovative and patient driven diagnostic service delivery model enabling individuals to request laboratory tests without a physician’s referral. This paper examines the concept and regulatory context of DAT in selected countries and explores its emerging practice specifically in the Philippines where DAT like services are already accessible despite the absence of a formal regulatory framework. A critical commentary of existing literature, regulatory documents, and published studies from the United States, Australia, and the Philippines was conducted to compare definitions, governance structures, and implementation practices. Findings indicate that countries such as the United States and Australia have integrated DAT within established regulatory systems that support patient-initiated testing while maintaining laboratory quality and safety standards. In contrast, the Philippine regulatory environment remains grounded in a physician centered model allowing patient-initiated testing to operate within a regulatory gray area. This gap between policy and practice raises concerns related to test appropriateness, result interpretation, patient safety, and continuity of care. The paper proposes the development of a risk based regulatory framework which includes the following policy aspirations: development of a national DAT Test List, mandatory pre and posttest patient guidance, accreditation standards for DAT providers, and integration of laboratory results into digital health systems. In simple terms, the paper argues that people should be able to access diagnostic tests more easily, but the rules must be updated so that this access is safe, high quality, and connected to proper care.